Comparison of Different Treatment Approaches in Carpal Tunnel Syndrome
NCT ID: NCT06238440
Last Updated: 2024-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-01-02
2024-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Kinesiotaping on paın, Function and electrophysiologıcal Findings in Patient With Carpal Tunnel Syndrome
NCT05592067
Mulligan Mobilization With Arm Movement in CTS Patients
NCT07042542
The Effectiveness of Neurodynamic Mobilization in Carpal Tunnel Syndrome
NCT06882707
Effectiveness of Kinesiotaping and Peloidotherapy in Carpal Tunnel Syndrome
NCT06977321
Effect of Kinesiotaping and Night Splinting in Patients With Carpal Tunnel Syndome
NCT04993703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
In the Splint (SP) group, in addition to the 10-session conventional physiotherapy program, individuals will be instructed to use the splint prescribed by the physician for 2 weeks.
In the Rigid Strapping (RB) group, along with the 10-session conventional physiotherapy program, a rigid strapping application will be performed by an experienced researcher at the end of each physiotherapy session, five days a week.
In the Kinesiotape (KT) group, in addition to the 10-session conventional physiotherapy program, kinesiotape application will be carried out by a certified researcher. To ensure homogeneity, individuals in both strapping groups will be asked to remove the tape before coming to treatment and reapply it at the end of the session. All participants included in the study will be evaluated twice, before and after treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
Splint and taping methods
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
Splint group: CG + Splint Rigid taping group: CG+ Rigid taping Kinesiotape: CG+ kinesiotape
Splint
In the Splint (SP) group, in addition to the 10-session conventional physiotherapy program, individuals will be instructed to use the splint prescribed by the physician for 2 weeks.
Splint and taping methods
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
Splint group: CG + Splint Rigid taping group: CG+ Rigid taping Kinesiotape: CG+ kinesiotape
Rigid taping
In the Rigid taping (RB) group, along with the 10-session conventional physiotherapy program, a rigid strapping application will be performed by an experienced researcher at the end of each physiotherapy session, five days a week.
Splint and taping methods
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
Splint group: CG + Splint Rigid taping group: CG+ Rigid taping Kinesiotape: CG+ kinesiotape
Kinesiotape
In the Kinesiotape (KT) group, in addition to the 10-session conventional physiotherapy program, kinesiotape application will be carried out by a certified researcher. To ensure homogeneity, individuals in both strapping groups will be asked to remove the tape before coming to treatment and reapply it at the end of the session.
Splint and taping methods
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
Splint group: CG + Splint Rigid taping group: CG+ Rigid taping Kinesiotape: CG+ kinesiotape
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Splint and taping methods
In the control group (CG), a conventional physiotherapy program will be implemented for 2 weeks. A 10-session treatment will be completed using thermal and electrical agents specified in the program prescribed by the physiotherapist.
Splint group: CG + Splint Rigid taping group: CG+ Rigid taping Kinesiotape: CG+ kinesiotape
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be in the age range of 18-65
* To be diagnosed with mild to moderate carpal tunnel syndrome (CTS) through median nerve conduction velocity studies
* To have experienced paresthesia, pain, and vasomotor symptoms in the area associated with the N. medianus for more than six weeks, as determined by studies on median nerve conduction.
* To test positive in Phalen, Tinel, or carpal compression tests
* To have been recommended splint therapy for CTS
Exclusion Criteria
* History of malignant tumor
* Use of a pacemaker
* Presence of severe electrodiagnostic findings (fibrotic changes in the median nerve)
* Another inflammatory condition (rheumatoid arthritis, tendinitis, etc.)
* Osteoarthritis in the hand/wrist
* Any musculoskeletal conditions affecting the hand, elbow, or wrist
* Yhyroid dysfunction
* Diagnosis of chronic kidney failure and undergoing treatment for it
* History of carpal tunnel surgery, upper extremity, and neck surgery and trauma
* Diagnosis of carpal tunnel syndrome associated with pregnancy or diabetes
* Having received any treatment for carpal tunnel syndrome (splint therapy, physical agents, exercise, local corticosteroid injection) up to 3 months before the tests
* Hypersensitivity (allergy to Kinesiotape or rigid strapping)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muğla Sıtkı Koçman University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Banu BAYAR
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Özge ipek Dongaz
Role: PRINCIPAL_INVESTIGATOR
Muğla Sıtkı Koçman University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muğla Sıtkı Koçman University
Muğla, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2/XIV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.